Albemarle (ALB-PA) EBIT (2009 - 2026)

Albemarle has reported EBIT for 18 years, with the latest figure at $501.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 2435.12% year-over-year to $501.0 million; the trailing twelve-month figure through Mar 2026 stood at $864.0 million (up 154.78% YoY), and the FY2025 full-year result was -$367.1 million, up 79.34% from the prior year.
• EBIT for Q1 2026 stood at $501.0 million, up from $197.9 million in the prior quarter.
• The five-year high for EBIT was $1.1 billion in Q1 2023, with the low at -$1.1 billion in Q3 2024.
• Historically, EBIT has averaged $107.6 million across 5 years, with a median of $117.6 million in 2025.
• Annual changes were most pronounced in 2024 — EBIT tumbled 691.94% — and 2025, when it soared 4396.46%.
• Albemarle's EBIT stood at $833.0 million in 2022, then sank by 202.02% to -$849.9 million in 2023, then surged by 100.52% to $4.4 million in 2024, then soared by 4396.46% to $197.9 million in 2025, then soared by 153.1% to $501.0 million in 2026.
• The last three EBIT figures came in at $501.0 million (Q1 2026), $197.9 million (Q4 2025), and $117.6 million (Q3 2025), per Business Quant data.